Macquarie Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160M | Sell |
|
|||||
|
2025
Q1 | $168M | Buy |
|
|||||
|
2024
Q4 | $130M | Buy |
|
|||||
|
2024
Q3 | $117M | Buy |
|
|||||
|
2024
Q2 | $85.2M | Sell |
|
|||||
|
2024
Q1 | $92.2M | Buy |
|
|||||
|
2023
Q4 | $102M | Buy |
|
|||||
|
2023
Q3 | $87.7M | Buy |
|
|||||
|
2023
Q2 | $89.5M | Sell |
|
|||||
|
2023
Q1 | $98.4M | Buy |
|
|||||
|
2022
Q4 | $97.1M | Buy |
|
|||||
|
2022
Q3 | $69M | Buy |
|
|||||
|
2022
Q2 | $68.3M | Sell |
|
|||||
|
2022
Q1 | $66K | Buy |
|
|||||
|
2021
Q4 | $47.2M | Buy |
|
|||||
|
2021
Q3 | $45.1M | Buy |
|
|||||
|
2021
Q2 | $25.4M | Buy |
|
|||||
|
2021
Q1 | $16.5M | Sell |
|
|||||
|
2020
Q4 | $21.3M | Buy |
|
|||||
|
2020
Q3 | $22.7M | Buy |
|
|||||
|
2020
Q2 | $26M | Sell |
|
|||||
|
2020
Q1 | $30.9M | Buy |
|
|||||
|
2019
Q4 | $25.9M | Buy |
|
|||||
|
2019
Q3 | $24.9M | Sell |
|
|||||
|
2019
Q2 | $26.6M | Sell |
|
|||||
|
2019
Q1 | $26.2M | Sell |
|
|||||
|
2018
Q4 | $26.3M | Sell |
|
|||||
|
2018
Q3 | $34.2M | Buy |
|
|||||
|
2018
Q2 | $29.4M | Buy |
|
|||||
|
2018
Q1 | $29.1M | Sell |
|
|||||
|
2017
Q4 | $27.7M | Sell |
|
|||||
|
2017
Q3 | $38.8M | Buy |
|
|||||
|
2017
Q2 | $26.8M | Sell |
|
|||||
|
2017
Q1 | $29.8M | Sell |
|
|||||
|
2016
Q4 | $35.3M | Sell |
|
|||||
|
2016
Q3 | $40.4M | Sell |
|
|||||
|
2016
Q2 | $97.3M | Buy |
|
|||||
|
2016
Q1 | $57.9M | Sell |
|
|||||
|
2015
Q4 | $70.3M | Sell |
|
|||||
|
2015
Q3 | $73.4M | Sell |
|
|||||
|
2015
Q2 | $88.1M | Sell |
|
|||||
|
2015
Q1 | $100M | Sell |
|
|||||
|
2014
Q4 | $97M | Sell |
|
|||||
|
2014
Q3 | $119M | Sell |
|
|||||
|
2014
Q2 | $105M | Buy |
|
|||||
|
2014
Q1 | $74.1M | Sell |
|
|||||
|
2013
Q4 | $81.1M | Sell |
|
|||||
|
2013
Q3 | $68.3M | Sell |
|
|||||
|
2013
Q2 | $58.6M | Buy |
|